| Name | Title | Contact Details |
|---|
Integrated Medical Management is a Las Vegas, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cherry Health is an independent, non-profit Federally Qualified Health Center (FQHC) with a primary focus of providing high quality health services to those who have little or no access to health care, regardless of income or insurance status. Services provided by Cherry Health include primary care, women`s health, pediatrics, dental, vision, behavioral health, mental health, correctional health, five school based health centers and employee assistance for employers. Cherry Health provides services to all individuals, regardless of their ability to pay. A sliding fee payment scale based on income and family size is available to those without insurance. Medicaid and Healthy Michigan are accepted, as are many other insurances. Established in 1988, Cherry Health is the largest FQHC in the state of Michigan serving Barry, Eaton, Kent, Montcalm and Wayne counties at more than 20 locations, 14 of which are primary care Federally Qualified Health Center sites, Cherry Health employs over 800 employees and a network of over 60 physicians and mid-level providers specializing in primary care/family medicine, pediatrics, internal medicine, obstetrics/gynecology, optometry and psychiatry. Additionally, Cherry Health runs a school linked program active in 70 public schools offering both vision and dental care.
Surface Oncology is a clinical-stage immuno-oncology company focused on using its specialized knowledge of the biological pathways critical to the immunosuppressive tumor microenvironment (TME) for the development of next-generation therapies to help patients suffering with cancer. Recent advances in understanding how the immune system fights cancer has created a first wave of immunotherapies with profound benefits for some patients. These first-generation therapies, or "checkpoint inhibitors", have been groundbreaking, but only a relatively small subset of patients is deriving long-term benefit. We believe that the lack of a broad and sustained clinical response is because these first-generation therapies only target one component of the immunosuppressive TME and a broader, more multi-faceted therapeutic approach is required. We are a team on a mission to deliver transformative outcomes for people with cancer by breaking through the frontiers of immuno-oncology research. Our diverse clinical and preclinical pipeline of immune-enhancing antibody candidates target the innate and adaptive arms of the immune system to deliver dramatically different therapies for patients and their families. Surface is leveraging its deep understanding of TME biology to target factors and cells that suppress patients’ anti-tumor immune response. Our broad attack on the TME has the potential to convert patients’ non-responsive ‘cold’ tumors into immune-active ones. We push ourselves to break through across all dimensions of our work. From a discovery perspective, Surface leverages its world-class SAB to identify new targets and takes an aggressive approach towards generating diverse, highly-specific antibodies, which allows our scientists to thoroughly explore the relevant biology. Our antibody discovery approach generates therapeutic-quality antibodies, as well as unique tools to explore the biology of the tumor microenvironment.
AGFA HealthCare Corporation is a Greenville, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AEGEA Medical was founded in 2008 to develop technology that aspires to utilize water vapor to treat a variety of women`s health conditions. Led by an experienced management team, and supported by a committed investor group, AEGEA Medical has established an expanding Intellectual Property (IP) portfolio.